Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pooling 12 nomifensine studies for efficacy generalizability.

D Gillings, J Grizzle, G Koch

    The Journal of Clinical Psychiatry
    |April 1, 1984
    PubMed
    Summary

    Nomifensine effectively treats depression across diverse patient groups, including older adults. Its efficacy is comparable to imipramine, particularly for acutely depressed patients with severe symptoms.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Using a community clinical trials network for treatment, prevention, and control research: assuring access to state-of-the-art cancer care.

    Cancer investigation·1995
    Same author

    Effect of a National Cancer Institute Clinical Alert on breast cancer practice patterns.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1994
    Same author

    Cancer prevention and control within the National Cancer Institute's clinical trials network: lessons from the Community Clinical Oncology Program.

    Journal of the National Cancer Institute·1993
    Same author

    The relationship between plasma beta-endorphin, opioid receptor activity, and silent myocardial ischemia.

    The Clinical journal of pain·1992
    Same author

    Tat contains a sequence related to snake neurotoxins.

    AIDS (London, England)·1992
    Same author

    Interrelationships between left ventricular volume and output during exercise in healthy subjects.

    Journal of applied physiology (Bethesda, Md. : 1985)·1992

    Area of Science:

    • Psychiatry
    • Clinical Pharmacology
    • Evidence-Based Medicine

    Background:

    • Depression is a prevalent mental health condition requiring effective pharmacotherapy.
    • Nomifensine is an antidepressant medication whose efficacy and safety profile warrants comprehensive evaluation.
    • Meta-analysis of randomized controlled trials (RCTs) provides robust evidence for treatment efficacy.

    Purpose of the Study:

    • To evaluate the efficacy and safety of nomifensine in treating depressed patients.
    • To assess the generalizability of nomifensine's efficacy across diverse patient populations.
    • To determine the conditions under which nomifensine demonstrates superior or comparable efficacy to other antidepressants like imipramine.

    Main Methods:

    • Pooling of data from twelve parallel-group, randomized, double-blind studies of nomifensine.

    Related Experiment Videos

  • Analysis of efficacy in moderate-sized patient pools and generalizability to the broader patient population.
  • Statistical assessment and power analysis of pooled active-controlled (nomifensine vs. imipramine) studies.
  • Main Results:

    • Nomifensine demonstrated statistically significant superiority over placebo in treating depression.
    • Efficacy of nomifensine was generalizable across a wide range of patient characteristics, including those aged 60 years and older.
    • Patients with shorter episode duration (<4 months), acute depression, severe symptoms, and prior treatment were identified as more pronounced nomifensine responders.
    • Pooled active-controlled studies provided strong evidence for the comparability of nomifensine and imipramine efficacy.

    Conclusions:

    • Nomifensine is an effective antidepressant with broad generalizability across patient demographics.
    • Specific patient profiles, such as those with acute, severe depression and prior treatment, are associated with more pronounced nomifensine response.
    • Nomifensine exhibits comparable efficacy to imipramine, supporting its role in depression management.